Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function-Reference-Cited by-同舟云学术

Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function

Published:2019 Issue:1 Volume:44 Page:47-56
ISSN:0388-1350
Container-title:The Journal of Toxicological Sciences
language:en
Short-container-title:J. Toxicol. Sci.

Author:

Wang Dawei¹,You Dong¹,Li Lei²

Affiliation:

1. Department of Radiotherapy, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, China

2. Department of Obstetrics, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, China

Publisher

Japanese Society of Toxicology

Subject

Toxicology

Link

https://www.jstage.jst.go.jp/article/jts/44/1/44_47/_pdf

Reference25 articles.

1. Agarwal, R. and Kaye, S.B. (2003): Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer, 3, 502-516.

2. Ali, A.Y., Farrand, L., Kim, J.Y., Byun, S., Suh, J.Y., Lee, H.J. and Tsang, B.K. (2012): Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum. Ann. N. Y. Acad. Sci., 1271, 58-67.

3. Barber, E.L., Dusetzina, S.B., Stitzenberg, K.B., Rossi, E.C., Gehrig, P.A., Boggess, J.F. and Garrett, J.M. (2017): Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival. Gynecol. Oncol., 145, 500-507.

4. Biswas, R., Ahn, J.C. and Kim, J.S. (2015): Sulforaphene Synergistically Sensitizes Cisplatin via Enhanced Mitochondrial Dysfunction and PI3K/PTEN Modulation in Ovarian Cancer Cells. Anticancer Res., 35, 3901-3908.

5. Bristow, N., Burton, T.R., Henson, E.S., Ong-Justiniano, C., Brown, M. and Gibson, S.B. (2011): Truncated forms of BNIP3 act as dominant negatives inhibiting hypoxia-induced cell death. Biochim. Biophys. Acta, 1812, 302-311.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma;British Journal of Cancer;2024-03-04

2. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors;Cancer Drug Resistance;2024-02-28

3. Exploring the tumor micro-environment in primary and metastatic tumors of different ovarian cancer histotypes;Frontiers in Cell and Developmental Biology;2024-01-24

4. Cadmium-Induced Neurotoxicity;Cadmium Toxicity Mitigation;2024

5. Exploring the tumor micro-environment in ovarian cancer histotypes and tumor sites;2023-10-10